Show simple item record

dc.contributor.authorGordon, Louisa G
dc.contributor.authorMerollini, Katharina MD
dc.contributor.authorLowe, Anthony
dc.contributor.authorChan, Raymond J
dc.date.accessioned2018-09-26T12:30:29Z
dc.date.available2018-09-26T12:30:29Z
dc.date.issued2017
dc.identifier.issn0311-306X
dc.identifier.urihttp://hdl.handle.net/10072/378221
dc.description.abstractThe term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the financial burden of cancer treatment. In much the same way as physical side-effects of treatment like fatigue, nausea or blood toxicities, financial problems after cancer diagnosis are a major contributor to poorer quality of life, treatment non-adherence and delayed medical care. This article describes what financial toxicity is, how it is measured, how common it is and what the implications are for further research and clinical practice. A recent review shows a wide range of measures used to describe the financial burden of cancer. Using monetary measures, the magnitude of financial stress was between 28-48% in cancer populations. Possible solutions to reduce the family financial burden include mandating full disclosure of doctors’ fees and charges related to treatment and strategies to empower patients to improve their treatment decision making. Furthermore, screening tools such as the COST-FACIT 11-item survey may assist health professionals to identify those patients at high risk of financial stress and refer them to support services. Minimising financial stress is important for patients and measuring financial toxicity helps to expose flaws in health systems and subsequently ensure that citizens receive quality cancer care.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherCancer Council Australia
dc.publisher.urihttps://www.cancer.org.au/health-professionals/resources/cancer-forum
dc.relation.ispartofpagefrom30
dc.relation.ispartofpageto35
dc.relation.ispartofissue2
dc.relation.ispartofjournalCancer Forum
dc.relation.ispartofvolume41
dc.subject.fieldofresearchOncology and Carcinogenesis not elsewhere classified
dc.subject.fieldofresearchOncology and Carcinogenesis
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode111299
dc.subject.fieldofresearchcode1112
dc.subject.fieldofresearchcode1117
dc.titleFinancial toxicity – what it is and how to measure it
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2017 Cancer Council Australia. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
gro.hasfulltextFull Text
gro.griffith.authorLowe, Anthony P.
gro.griffith.authorChan, Ray
gro.griffith.authorGordon, Louisa


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record